search
Back to results

Mindfulness Based Smoking Cessation Among Cancer Survivors

Primary Purpose

Tobacco Smoking

Status
Recruiting
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Nicoderm C-Q Transdermal Product
Orientation session
Craving-to-Quit app
Two brief follow-up phone calls
Group MT sessions
Brief advice on quitting smoking
Self-help smoking cessation materials
Sponsored by
University of Miami
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Tobacco Smoking focused on measuring cancer, nicotine replacement therapy, mindfulness

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Be 18-40 years old (young cancer survivors)
  • Cancer survivors (based on the NCI definition - "a person is considered to be a survivor from the time of diagnosis until the end of life" National Cancer Institute Dictionary of Cancer Terms, 2014)52
  • Have smoked ≥ 5 cigarettes/day in the past year
  • Be interested in making a quit attempt in the next 30 days
  • Own a smartphone (apple/android)
  • Read/speak English
  • Able to consent
  • Have no plans to move in the next 3 months
  • Are not pregnant or planning to be pregnant in the following 3 months

Exclusion Criteria:

  • Have contraindication to NRT (past month myocardial infarction, history of serious arrhythmias/or unstable angina pectoris, dermatological disorder)
  • Have cognitive/mental health impairment that inhibits mindfulness treatment
  • Are currently in active cancer treatment
  • Are currently being treated for smoking cessation, alcoholism, or illicit drug use
  • Are adults unable to consent
  • Are individuals who are not yet adults
  • Are pregnant women
  • Are prisoners

Sites / Locations

  • University of MiamiRecruiting
  • St. Jude Children's Research HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Experimental

Experimental

Arm Label

Usual Care

Craving-to-Quit app

In-person Mindfulness Training

Arm Description

Participants in this group will receive a brief advice to quit smoking, 6-week supplies of nicotine replacement therapy (NRT), and self-help materials to quit smoking.

Participants in this group will receive one in-person orientation session, 6-week supply of NRT, the "Craving-to-Quit" app, and two brief follow-up phone calls.

Participants in this group will receive twice weekly group sessions (eight total during 4 weeks) that were manualized and delivered by instructors experienced in Mindfulness Training (MT) (a single therapist with >4 years of training in MT).

Outcomes

Primary Outcome Measures

Number of participants with confirmed smoking abstinence
self-report of not smoking in the past 7-days, not even a puff, confirmed by expired carbon monoxide (CO) level of < 10 ng/ml

Secondary Outcome Measures

Change in number of cigarettes smoked per day
Self-reported number of cigarettes smoked per day by each participant (Question is: On average, how many cigarettes do you smoke per day?)
Number of participants with reported relapse
Relapse is defined as smoking at least once/week on two consecutive weeks.
Usability of the Craving-to-Quit app as assessed by the number of times participant logged in the app
How usable participants found the app measured by the absolute number of times logged into the app.
Usability of the Craving-to-Quit app as assessed by the number of days of completed app use
How usable participants found the app measured by self-reported number of completed days for the app.
Usability of the Craving-to-Quit app as assessed by the comfortability with the app
How usable participants found the app measured by the comfortability of the app via questionnaire with scores ranging from 0-10 with the higher score indicating increased comfortability with the app.
Acceptability
Assessed by 3 items "How satisfied were you with the intervention?", "How likely are you to recommend this intervention to a friend?" and "How useful was the intervention?" Each question is scored from 0-10 with the higher score indicating increased acceptability.
Feasibility of recruitment as assessed via enrollment rate
A feasible recruitment is defined as an enrollment rate of 70% or higher.
Attrition
Defined as the number of participants not having a final visit at the end of treatment, categories include mortality, withdrawal from the study, transfer to non-study clinics, loss to follow-up without identifiable cause.

Full Information

First Posted
July 26, 2019
Last Updated
August 11, 2023
Sponsor
University of Miami
search

1. Study Identification

Unique Protocol Identification Number
NCT04038255
Brief Title
Mindfulness Based Smoking Cessation Among Cancer Survivors
Official Title
Smartphone Application Versus In-person Mindfulness-based Smoking Cessation Intervention for Young Cancer Survivors: Reach Versus Effectiveness
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 28, 2019 (Actual)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
September 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Miami

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will examine the effect of a mindfulness-based smoking cessation program among cancer survivors.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tobacco Smoking
Keywords
cancer, nicotine replacement therapy, mindfulness

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Usual Care
Arm Type
Active Comparator
Arm Description
Participants in this group will receive a brief advice to quit smoking, 6-week supplies of nicotine replacement therapy (NRT), and self-help materials to quit smoking.
Arm Title
Craving-to-Quit app
Arm Type
Experimental
Arm Description
Participants in this group will receive one in-person orientation session, 6-week supply of NRT, the "Craving-to-Quit" app, and two brief follow-up phone calls.
Arm Title
In-person Mindfulness Training
Arm Type
Experimental
Arm Description
Participants in this group will receive twice weekly group sessions (eight total during 4 weeks) that were manualized and delivered by instructors experienced in Mindfulness Training (MT) (a single therapist with >4 years of training in MT).
Intervention Type
Drug
Intervention Name(s)
Nicoderm C-Q Transdermal Product
Intervention Description
6 weeks of nicotine replacement therapy patches
Intervention Type
Behavioral
Intervention Name(s)
Orientation session
Intervention Description
This session will occur 2 weeks before quit date. It will be moderated by a certified instructor in MT, and will last approximately 90 min. During the session, participants will learn the purpose, format, and procedures of the study, provide written informed consent, and complete the baseline assessment.
Intervention Type
Behavioral
Intervention Name(s)
Craving-to-Quit app
Intervention Description
The app is comprised of 22 modules for 22 days, 5-15 minutes each, designed to teach MT using audio, video, and animation. The app also includes other features such as social support (quit friend sign-ups, the tip of the week), activity feed (to track interaction with the app), and my morning stats (to track smoking).
Intervention Type
Behavioral
Intervention Name(s)
Two brief follow-up phone calls
Intervention Description
The first phone call will occur one day before the quit date to remind participants about their quit date and provide support. The second will occur at the end of treatment (around day 60 after quit date) to review progress, provide support, and schedule the 3-month follow-up visit. Each phone call will last approximately 15 minutes.
Intervention Type
Behavioral
Intervention Name(s)
Group MT sessions
Intervention Description
Total of eight group sessions (twice a week) during 4 weeks. The overarching theme of momentary awareness and acceptance of cravings and affect (e.g., stress, anxiety etc.) will be introduced and reinforced in complementary ways throughout the training. Each session will last 45-60 minutes.
Intervention Type
Behavioral
Intervention Name(s)
Brief advice on quitting smoking
Intervention Description
Standard advice on how to quit smoking.
Intervention Type
Behavioral
Intervention Name(s)
Self-help smoking cessation materials
Intervention Description
Written materials on how to quit smoking including contact info for state tobacco quitline.
Primary Outcome Measure Information:
Title
Number of participants with confirmed smoking abstinence
Description
self-report of not smoking in the past 7-days, not even a puff, confirmed by expired carbon monoxide (CO) level of < 10 ng/ml
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Change in number of cigarettes smoked per day
Description
Self-reported number of cigarettes smoked per day by each participant (Question is: On average, how many cigarettes do you smoke per day?)
Time Frame
Baseline, 3 months
Title
Number of participants with reported relapse
Description
Relapse is defined as smoking at least once/week on two consecutive weeks.
Time Frame
3 months
Title
Usability of the Craving-to-Quit app as assessed by the number of times participant logged in the app
Description
How usable participants found the app measured by the absolute number of times logged into the app.
Time Frame
3 months
Title
Usability of the Craving-to-Quit app as assessed by the number of days of completed app use
Description
How usable participants found the app measured by self-reported number of completed days for the app.
Time Frame
3 months
Title
Usability of the Craving-to-Quit app as assessed by the comfortability with the app
Description
How usable participants found the app measured by the comfortability of the app via questionnaire with scores ranging from 0-10 with the higher score indicating increased comfortability with the app.
Time Frame
3 months
Title
Acceptability
Description
Assessed by 3 items "How satisfied were you with the intervention?", "How likely are you to recommend this intervention to a friend?" and "How useful was the intervention?" Each question is scored from 0-10 with the higher score indicating increased acceptability.
Time Frame
3 months
Title
Feasibility of recruitment as assessed via enrollment rate
Description
A feasible recruitment is defined as an enrollment rate of 70% or higher.
Time Frame
Baseline
Title
Attrition
Description
Defined as the number of participants not having a final visit at the end of treatment, categories include mortality, withdrawal from the study, transfer to non-study clinics, loss to follow-up without identifiable cause.
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Be 18 years and older Cancer survivors (based on the NCI definition - "a person is considered to be a survivor from the time of diagnosis until the end of life" National Cancer Institute Dictionary of Cancer Terms, 2014) Cancer patients currently in active treatment Have smoked ≥ 5 cigarettes/day in the past year Be interested in making a quit attempt in the next 30 days Own a smartphone (apple/android) Read/speak English Able to consent Have no plans to move in the next 3 months Are not pregnant or planning to be pregnant in the following 3 months Exclusion Criteria: Have contraindication to NRT (past month myocardial infarction, history of serious arrhythmias/or unstable angina pectoris, dermatological disorder) Have cognitive/mental health impairment that inhibits mindfulness treatment Are currently using any non-cigarette tobacco products Are currently being treated for smoking cessation, alcoholism, or illicit drug use Are adults unable to consent Are individuals who are not yet adults Are pregnant women Are prisoners
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Taghrid Asfar, MD
Phone
305-243-3826
Email
tasfar@miami.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Lily Friedman
Phone
609-647-5800
Email
lxf699@miami.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Taghrid Asfar, MD
Organizational Affiliation
University of Miami
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Miami
City
Miami
State/Province
Florida
ZIP/Postal Code
33136
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lily Friedman, BS
Phone
609-647-5800
Email
lxf699@miami.edu
First Name & Middle Initial & Last Name & Degree
Taghrid Asfar, MD
Facility Name
St. Jude Children's Research Hospital
City
Memphis
State/Province
Tennessee
ZIP/Postal Code
38105
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tara M Brinkman
Email
tara.brinkman@stjude.org
First Name & Middle Initial & Last Name & Degree
Ruth Eliason
Email
ruth.eliason@stjude.org

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Mindfulness Based Smoking Cessation Among Cancer Survivors

We'll reach out to this number within 24 hrs